Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinbo Yuan

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 20, 2015
Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling PathwaysLin Zhou, Qian Liu, Mingli Yang, et al.
Frontiers in Cell and Developmental Biology|June 26, 2020
Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast FunctionShangfu Li, Tianwei He, Depeng Wu, et al.
Journal of Cellular Physiology|March 10, 2018
Carnosic acid inhibits inflammation response and joint destruction on osteoclasts, fibroblast-like synoviocytes, and collagen-induced arthritis ratsMei Liu, Xiaotian Zhou, Lin Zhou, et al.
Frontiers in Pharmacology|June 21, 2021
Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis <i>via</i> Repressing RANKL Signaling and Reactive Oxygen SpeciesDelong Chen, Qingqing Wang, Ying Li, et al.
The Journal of Physiology|November 3, 2021
Long-term exposure of mice to 890 ppm atmospheric CO<sub>2</sub> alters growth trajectories and elicits hyperactive behaviours in young adulthoodCaitlin S Wyrwoll, Melissa G Papini, Emily K Chivers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 27, 2019
Cumambrin A prevents OVX-induced osteoporosis <i>via</i> the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathwaysLin Zhou, Qian Liu, Guoju Hong, et al.
Cell Death & Disease|September 17, 2020
PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncouplingShangfu Li, Qiuli Liu, Depeng Wu, et al.
Journal of Cellular Physiology|November 19, 2021
Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathwaysGang Wang, Kai Chen, Chao Ma, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 25, 2026
Roburic acid inhibits glucocorticoid-induced osteonecrosis of the femoral head associated osteoclast activity via targeting PTP1BGang Wang, Liang Mo, Chao Wang, et al.
Frontiers in Pharmacology|October 11, 2021
Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS ActivityJianbo He, Kai Chen, Tiancheng Deng, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 20, 2015
Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling PathwaysLin Zhou, Qian Liu, Mingli Yang, et al.
Frontiers in Cell and Developmental Biology|June 26, 2020
Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast FunctionShangfu Li, Tianwei He, Depeng Wu, et al.
Journal of Cellular Physiology|March 10, 2018
Carnosic acid inhibits inflammation response and joint destruction on osteoclasts, fibroblast-like synoviocytes, and collagen-induced arthritis ratsMei Liu, Xiaotian Zhou, Lin Zhou, et al.
Frontiers in Pharmacology|June 21, 2021
Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis <i>via</i> Repressing RANKL Signaling and Reactive Oxygen SpeciesDelong Chen, Qingqing Wang, Ying Li, et al.
The Journal of Physiology|November 3, 2021
Long-term exposure of mice to 890 ppm atmospheric CO<sub>2</sub> alters growth trajectories and elicits hyperactive behaviours in young adulthoodCaitlin S Wyrwoll, Melissa G Papini, Emily K Chivers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 27, 2019
Cumambrin A prevents OVX-induced osteoporosis <i>via</i> the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathwaysLin Zhou, Qian Liu, Guoju Hong, et al.
Cell Death & Disease|September 17, 2020
PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncouplingShangfu Li, Qiuli Liu, Depeng Wu, et al.
Journal of Cellular Physiology|November 19, 2021
Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathwaysGang Wang, Kai Chen, Chao Ma, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 25, 2026
Roburic acid inhibits glucocorticoid-induced osteonecrosis of the femoral head associated osteoclast activity via targeting PTP1BGang Wang, Liang Mo, Chao Wang, et al.
Frontiers in Pharmacology|October 11, 2021
Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS ActivityJianbo He, Kai Chen, Tiancheng Deng, et al.
Pageof 4